Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study

Journal of the American Academy of Dermatology

Volumn 74, Issue 2, 2016, Pages 295-302

  Gill, Liza ^a   Zarbo, Allison ^b   Isedeh, Prescilia ^c   Jacobsen, Gordon ^c   Lim, Henry W ^c   Hamzavi, Iltefat ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

alopecia areata; associations; autoimmune disease; comorbidities; prevalence; thyroid disease; vitiligo

Indexed keywords

ANTINUCLEAR ANTIBODY; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ADOLESCENT; ADULT; AGE; AGED; ALOPECIA AREATA; AUTOIMMUNE DISEASE; CHILD; COHORT ANALYSIS; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; DISCOID LUPUS ERYTHEMATOSUS; DISEASE DURATION; FEMALE; GRAVES DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORPHEA; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; ONSET AGE; PEMPHIGUS VULGARIS; PERNICIOUS ANEMIA; PRIORITY JOURNAL; PSORIASIS; RACE DIFFERENCE; RHEUMATIC FEVER; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; VITILIGO; ANEMIA, PERNICIOUS; AUTOIMMUNE DISEASES; BODY SURFACE; COMORBIDITY; ETHNOLOGY; GUILLAIN-BARRE SYNDROME; HASHIMOTO DISEASE; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; PREVALENCE; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; THYROID DISEASES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALOPECIA AREATA; ANEMIA, PERNICIOUS; AUTOIMMUNE DISEASES; BODY SURFACE AREA; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GRAVES DISEASE; GUILLAIN-BARRE SYNDROME; HASHIMOTO DISEASE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INFLAMMATORY BOWEL DISEASES; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREVALENCE; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SJOGREN'S SYNDROME; THYROID DISEASES; VITILIGO; YOUNG ADULT;

EID: 84973410548     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.08.063     Document Type: Conference Paper

References (42)

1. 1 Alikhan, A., Felsten, L.M., Daly, M., Petronic-Rosic, V., Vitiligo: a comprehensive overview, part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 65 (2011), 473–491.
2. 2 Laddha, N.C., Dwivedi, M., Mansuri, M.S., et al. Vitiligo: interplay between oxidative stress and immune system. Exp Dermatol 22 (2013), 245–250.
3. 3 Spritz, R.A., The genetics of vitiligo. J Invest Dermatol 131 (2011), E18–E20.
4. 4 Alkhateeb, A., Fain, P.R., Thody, A., Bennett, D.C., Spritz, R.A., Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16 (2003), 208–214.
5. 5 Laberge, G., Mailloux, C.M., Gowan, K., et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 18 (2005), 300–305.
6. 6 Sharma, V.K., Dawn, G., Kumar, B., Profile of alopecia areata in Northern India. Int J Dermatol 35 (1996), 22–27.
7. 7 Sharma, V.K., Kumar, B., Dawn, G., A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr Dermatol 13 (1996), 372–377.
8. 8 Sheth, V.M., Guo, Y., Qureshi, A.A., Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology 227 (2013), 311–315.
9. 9 Amerio, P., Di Rollo, D., Carbone, A., et al. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol 20 (2010), 354–358.
10. 10 Narita, T., Oiso, N., Fukai, K., Kabashima, K., Kawada, A., Suzuki, T., Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int 60 (2011), 505–508.
11. 11 Chu, S.Y., Chen, Y.J., Tseng, W.C., et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol 65 (2011), 949–956.
12. 12 Huang, K.P., Mullangi, S., Guo, Y., Qureshi, A.A., Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol 149 (2013), 789–794.
13. 13 Zelissen, P.M., Bast, E.J., Croughs, R.J., Associated autoimmunity in Addison's disease. J Autoimmun 8 (1995), 121–130.
14. 14 Dawber, R.P., Integumentary associations of pernicious anemia. Br J Dermatol 82 (1970), 221–223.
15. 15 Grunnet, I., Howitz, J., Reymann, F., Schwartz, M., Vitiligo and pernicious anemia. Arch Dermatol 101 (1970), 82–85.
16. 16 Ezzedine, K., Lim, H.W., Suzuki, T., et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 25 (2012), E1–E13.
17. 17 Silverberg, J.I., Silverberg, N.B., Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol 149 (2013), 159–164.
18. 18 Lim, H.W., Hexsel, C.L., Vitiligo: to treat or not to treat. Arch Dermatol 143 (2007), 643–646.
19. 19 Hayter, S.M., Cook, M.C., Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 11 (2012), 754–765.
20. 20 Di Cesare, A., Di Meglio, P., Nestle, F.O., The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129 (2009), 1339–1350.
21. 21 Lowes, M.A., Kikuchi, T., Fuentes-Duculan, J., et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128 (2008), 1207–1211.
22. 22 Hollander, M., Wolfe, D., The two-sample location problem. Hollander, M., Wolfe, D., (eds.) Nonparametric statistical methods, 1973, John Wiley and Sons Inc, New York (NY), 67–82.
23. 23 Sheskin, D.J., The chi-square test for r x c tables. Sheskin, D.J., (eds.) Handbook of parametric and nonparametric statistical procedures, 2000, Chapman and Hall/CRC, Boca Raton (FL), 359–430.
24. 24 Noonan, C.W., Williamson, D.M., Henry, J.P., et al. The prevalence of multiple sclerosis in 3 US communities. Prev Chronic Dis, 7, 2010, A12.
25. 25 Safavi, K., Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol, 128, 1992, 702.
26. 26 Safavi, K.H., Muller, S.A., Suman, V.J., Moshell, A.N., Melton, L.J. III, Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 70 (1995), 628–633.
27. 27 Alshekhlee, A., Hussain, Z., Sultan, B., Katirji, B., Guillain-Barre syndrome: incidence and mortality rates in US hospitals. Neurology 70 (2008), 1608–1613.
28. 28 Kappelman, M.D., Rifas-Shiman, S.L., Kleinman, K., et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5 (2007), 1424–1429.
29. 29 Somers, E.C., Marder, W., Cagnoli, P., et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance (MILES) program. Arthritis Rheum 66 (2013), 369–378.
30. 30 Hollowell, J.G., Staehling, N.W., Flanders, W.D., et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87 (2002), 489–499.
31. 31 Saleh, M.N., Fisher, M., Grotzinger, K.M., Analysis of the impact and burden of illness of adult chronic ITP in the US. Curr Med Res Opin 25 (2009), 2961–2969.
32. 32 International Pemphigus & Pemphigoid Foundation. Pemphigus. Available at: http://www.pemphigus.org/research/clinically-speaking/pemphigus/. Accessed March 29, 2014.
33. 33 US Census Bureau. 2006-2010 American community survey. Table B01003: Total population. Available at: http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ACS_10_5YR_B01003&prodType=table. Published May 2011. Accessed March 26, 2014.
34. 34 Furst, D.E., Fernandes, A.W., Iorga, S.R., Greth, W., Bancroft, T., Epidemiology of systemic sclerosis in a large US managed care population. J Rheumatol 39 (2012), 784–786.
35. 35 Pettitt, D.J., Talton, J., Dabelea, D., et al. Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study. Diabetes Care 37 (2014), 402–408.
36. 36 Suhler, E.B., Lloyd, M.J., Choi, D., Rosenbaum, J.T., Austin, D.F., Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest. Am J Ophthalmol 146 (2008), 890–896.e8.
37. 37 Rachakonda, T.D., Schupp, C.W., Armstrong, A.W., Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 70 (2014), 512–516.
38. 38 Myasoedova, E., Crowson, C.S., Kremers, H.M., Therneau, T.M., Gabriel, S.E., Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 62 (2010), 1576–1582.
39. 39 Maitra, A., The endocrine system. Kumar, V., Abbas, A.K., Fausto, N., Aster, J.C., (eds.) Robbins and Cotran pathologic basis of disease, 2010, Saunders, Philadelphia (PA), 1097–1164.
40. 40 Chen, Y., Chen, Y., Hwang, C., et al. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol 29 (2015), 1362–1369.
41. 41 Ingordo, V., Cazzaniga, S., Raone, B., et al. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study. Dermatology 228 (2014), 240–249.
42. 42 Wu, J.J., Nguyen, T.U., Poon, K.Y., Herrinton, L.J., The association of psoriasis with autoimmune diseases. J Am Acad Dermatol 67 (2012), 924–930.